Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra®

NEXT STORY
Ivy Brain Tumor Center and BridgeBio Pharma’s QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent Glioblastoma
PREV STORY
Sierra Oncology Appoints Christina Thomson as General Counsel
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

In-Vitro Diagnostics (IVD) Market Slated to Bring in USD 102,554.24 million by End of 2023 | POC Testing to Expedite In-vitro Diagnostics Industry Demand, Says MRFR

author_avatar
NASDAQ Market News

Guardant Health Reports First Quarter 2020 Financial Results

author_avatar
NASDAQ Market News

TRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary of Biocytogen, Announce Partnership for Development of Clinical Stage CTLA-4 Antibody YH001

author_avatar
NASDAQ Market News